Endothelial dysfunction in type 1 diabetes

被引:6
|
作者
Bertoluci, Marcello Casaccia [1 ,2 ]
Ce, Gislaine Vissoky [2 ,5 ]
Da Silva, Antonio Marcos V. [3 ,4 ]
Punales, Marcia K. C. [5 ]
机构
[1] Univ Fed Rio Grande do Sul, Dept Med Interna, Porto Alegre, RS, Brazil
[2] Univ Fed Rio Grande do Sul, Programa Pos Grad Ciencias Med, Porto Alegre, RS, Brazil
[3] Univ Santa Cruz do Sul, Porto Alegre, RS, Brazil
[4] Univ Fed Rio Grande do Sul, Programa Pos Grad Ciencias Biol, Porto Alegre, RS, Brazil
[5] Grp Hosp Conceicao, ICD, Porto Alegre, RS, Brazil
关键词
endothelial dysfunction; type; 1; diabetes; nitric oxide; atherosclerosis;
D O I
10.1590/S0004-27302008000200030
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Vascular complications are the main cause of mortality and morbidity in diabetes. Mechanisms involved in the development of micro and macrovascular disease are complex and partially understood, but invariably begin as a dysfunctional endothelium. Nitric oxide is an important regulator of endothelial function and the impairment of its activity is determinant of the endothelial dysfunction. In type 1 diabetes, many factors like acute, chronic and postprandial hyperglycemia, as well as the duration of diabetes or autonomic neuropathy and microalbuminuria are associated to endothelial dysfunction. Oxidative stress, polyol pathway activation, protein kinase C activation and the presence of advanced glycation rend-products are potential mechanisms involved in the development of endothelial dysfunction. Early detection of endothelial dysfunction has prognostic value for the. development of vascular complications and may be important in strategies for primary prevention of cardiovascular endpoints in type 1 diabetes.
引用
收藏
页码:416 / 426
页数:11
相关论文
共 50 条
  • [21] Cardiorenal syndrome in type 1 diabetes mellitus: The role of endothelial dysfunction
    Shestakova, MV
    Yarek-Martynova, IR
    Ivanishina, NS
    Alexandrov, AA
    Dedov, II
    KARDIOLOGIYA, 2005, 45 (06) : 35 - 41
  • [22] Endothelial dysfunction, CIMT and lipoproteins in young people with Type 1 diabetes
    Sibal, L.
    Jones, A.
    Neely, D.
    Mitchell, G.
    Razvi, S.
    Weaver, J. U.
    Oates, C. P.
    Home, P. D.
    DIABETIC MEDICINE, 2008, 25
  • [23] Hyperglycemia and Endothelial Dysfunction in Atherosclerosis: Lessons from Type 1 Diabetes
    Funk, Steven Daniel
    Yurdagul, Arif, Jr.
    Orr, A. Wayne
    INTERNATIONAL JOURNAL OF VASCULAR MEDICINE, 2012, 2012
  • [24] Vascular Endothelial Dysfunction and Nutritional Compounds in Early Type 1 Diabetes
    Hoffman, Robert P.
    CURRENT DIABETES REVIEWS, 2014, 10 (03) : 201 - 207
  • [25] Postprandial studies unmask endothelial dysfunction in subjects with type 1 diabetes
    McGowan, A.
    Widdowson, W. M.
    Boran, G.
    Moore, K.
    Gibney, J.
    IRISH JOURNAL OF MEDICAL SCIENCE, 2016, 185 : 374 - 375
  • [26] Endothelial dysfunction in patients with diabetes mellitus type 1 and diabetic cardiomyopathy
    Ribchenko, J. B.
    Sokolova, L.
    Voloshina, O.
    Efimov, A.
    Tronko, N.
    DIABETOLOGIA, 2006, 49 : 717 - 718
  • [27] Endothelial dysfunction in type 2 diabetes mellitus
    Avogaro, A
    Fadini, GP
    Gallo, A
    Pagnin, E
    de Kreutzenberg, S
    NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2006, 16 : S39 - S45
  • [28] Endothelial Dysfunction in Type 2 Diabetes Mellitus
    Dhananjayan R.
    Koundinya K.S.S.
    Malati T.
    Kutala V.K.
    Indian Journal of Clinical Biochemistry, 2016, 31 (4) : 372 - 379
  • [29] Endothelial dysfunction and type 2 diabetes Part 1:: physiology and methods for exploring the endothelial function
    Guerci, B
    Kearney-Schwartz, A
    Böhme, P
    Zannad, F
    Drouin, P
    DIABETES & METABOLISM, 2001, 27 (04) : 425 - 434
  • [30] ADIPOCYTOKINES AND OBESITY ARE ASSOCIATED WITH ENDOTHELIAL DYSFUNCTION AND RETINOPATHY DEVELOPMENT IN TYPE 1 DIABETES
    Tomic, M.
    Vrabec, R.
    Bulum, T.
    Roso, V.
    Vuckovic-Rebrina, S.
    Lovrencic, M. Vucic
    Duvnjak, L.
    EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2019, 29 (03) : NP26 - NP27